Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07423637Not ApplicableNot Yet Recruiting

The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment

Role: collaborator

NCT05793645Not ApplicableUnknown

Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program

Role: collaborator

NCT01977014Completed

NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

Role: lead

All 3 trials loaded